Published in J Immunol on December 01, 1991
A small bispecific antibody construct expressed as a functional single-chain molecule with high tumor cell cytotoxicity. Proc Natl Acad Sci U S A (1995) 1.46
Organ involvement and phenotypic adhesion profile of 5T2 and 5T33 myeloma cells in the C57BL/KaLwRij mouse. Br J Cancer (1997) 1.30
"Peptabody": a new type of high avidity binding protein. Proc Natl Acad Sci U S A (1997) 1.00
An anti-CD19 antibody coupled to a tetanus toxin peptide induces efficient Fas ligand (FasL)-mediated cytotoxicity of a transformed human B cell line by specific CD4+ T cells. Clin Exp Immunol (1998) 0.76
Generation of chimeric bispecific G250/anti-CD3 monoclonal antibody, a tool to combat renal cell carcinoma. Br J Cancer (1996) 0.75
Identification of a monoclonal antibody specific for a murine T3 polypeptide. Proc Natl Acad Sci U S A (1987) 14.24
Prion protein (PrP) with amino-proximal deletions restoring susceptibility of PrP knockout mice to scrapie. EMBO J (1996) 6.66
CD8alpha+ and CD8alpha- subclasses of dendritic cells direct the development of distinct T helper cells in vivo. J Exp Med (1999) 6.06
Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia. European Organization for Research and Treatment of Cancer--Childhood Leukemia Cooperative Group. N Engl J Med (1998) 4.95
Risk of cancer after low doses of ionising radiation: retrospective cohort study in 15 countries. BMJ (2005) 4.91
Regulation of dendritic cell numbers and maturation by lipopolysaccharide in vivo. J Exp Med (1996) 4.70
The 15-Country Collaborative Study of Cancer Risk among Radiation Workers in the Nuclear Industry: estimates of radiation-related cancer risks. Radiat Res (2007) 4.41
Prion (PrPSc)-specific epitope defined by a monoclonal antibody. Nature (1997) 4.03
Effect of interleukin-10 on dendritic cell maturation and function. Eur J Immunol (1997) 2.81
The B-cell surface protein CD72/Lyb-2 is the ligand for CD5. Nature (1991) 2.76
Myeloid dendritic cells induce Th2 responses to inhaled antigen, leading to eosinophilic airway inflammation. J Clin Invest (2000) 2.67
FHL2, a novel tissue-specific coactivator of the androgen receptor. EMBO J (2000) 2.25
Altered circadian activity rhythms and sleep in mice devoid of prion protein. Nature (1996) 2.24
Regulatory roles of AP-2 transcription factors in vertebrate development, apoptosis and cell-cycle control. Gene (2000) 2.07
Antigen-pulsed dendritic cells can efficiently induce an antibody response in vivo. J Exp Med (1992) 2.05
Basal level of anti-Müllerian hormone is associated with oocyte quality in stimulated cycles. Hum Reprod (2006) 2.03
[Recommendations for management of dyslipidemia in 2014]. Rev Med Suisse (2014) 2.02
B lymphocytes regulate dendritic cell (DC) function in vivo: increased interleukin 12 production by DCs from B cell-deficient mice results in T helper cell type 1 deviation. J Exp Med (2000) 2.02
A clinical trial of anti-idiotype therapy for B cell malignancy. Blood (1985) 1.91
NK cell receptors and their ligands in leukemia. Leukemia (2007) 1.78
Validation of a western immunoblotting procedure for bovine PrP(Sc) detection and its use as a rapid surveillance method for the diagnosis of bovine spongiform encephalopathy (BSE). Acta Neuropathol (1999) 1.76
Mouse x human heterohybridomas as fusion partners with human B cell tumors. J Immunol Methods (1986) 1.73
Enhanced blood coagulation and fibrinolysis in mice lacking histidine-rich glycoprotein (HRG). J Thromb Haemost (2005) 1.72
A medical report from the stone age? Lancet (1999) 1.70
White-coat hypertension--to treat or not to treat: a clinical dilemma. Arch Intern Med (2001) 1.70
Identification of MAGE-3 epitopes presented by HLA-DR molecules to CD4(+) T lymphocytes. J Exp Med (1999) 1.67
Expression cloning of an interferon-inducible 17-kDa membrane protein implicated in the control of cell growth. J Biol Chem (1995) 1.64
Lysis of anti-T3-bearing murine hybridoma cells by human allospecific cytotoxic T cell clones and inhibition of that lysis by anti-T3 and anti-LFA-1 antibodies. J Immunol (1985) 1.62
Induction of fibrinogen binding and platelet aggregation as a potential intrinsic property of various glycoprotein IIb/IIIa (alphaIIbbeta3) inhibitors. Blood (1998) 1.61
Heparin inhibits ligand binding to the leukocyte integrin Mac-1 (CD11b/CD18). Circulation (1999) 1.58
Murine dendritic cells pulsed in vitro with tumor antigen induce tumor resistance in vivo. Eur J Immunol (1994) 1.58
HLA association of amoxicillin-clavulanate--induced hepatitis. Gastroenterology (1999) 1.56
Cough and ACE inhibitors. Arch Intern Med (1992) 1.52
Cytokines regulate the capacity of CD8alpha(+) and CD8alpha(-) dendritic cells to prime Th1/Th2 cells in vivo. J Immunol (2001) 1.51
Idiotypic regulation of the immune system. Common idiotypic specificities between idiotypes and antibodies raised against anti-idiotypic antibodies in rabbits. J Exp Med (1979) 1.51
Glucocorticoids down-regulate dendritic cell function in vitro and in vivo. Eur J Immunol (1995) 1.46
Nature and rate of vascular refilling during hemodialysis and ultrafiltration. Kidney Int (1992) 1.46
Prognostic value of first polar body morphology on fertilization rate and embryo quality in intracytoplasmic sperm injection. Hum Reprod (2000) 1.44
Recent evidence on drug therapy of mild to moderate hypertension and decreased risk of coronary heart disease. Arch Intern Med (1993) 1.44
Proinflammatory cytokines and their role in the development of major transplant-related complications in the early phase after allogeneic bone marrow transplantation. Leukemia (2003) 1.43
Evidence that multiple myeloma Ig heavy chain VDJ genes contain somatic mutations but show no intraclonal variation. Blood (1992) 1.42
Diazoxide--an effective vasodilator in accelerated hypertension. Am Heart J (1974) 1.41
Identification of monoclonal antibodies specific for the T cell receptor complex by Fc receptor-mediated CTL lysis. J Immunol (1986) 1.40
Decreased nociceptive sensitivity: a biological risk marker for opiate dependence? Addiction (1997) 1.40
The 15-Country Collaborative Study of Cancer Risk Among Radiation Workers in the Nuclear Industry: design, epidemiological methods and descriptive results. Radiat Res (2007) 1.37
Genes encoding tumor-specific antigens are expressed in human myeloma cells. Blood (1999) 1.37
CTLA4-Ig restores rejection of MHC class-II mismatched allografts by disabling IL-2-expanded regulatory T cells. Am J Transplant (2012) 1.36
Selection based on morphological assessment of oocytes and embryos at different stages of preimplantation development: a review. Hum Reprod Update (2003) 1.34
Dendritic cell subsets and the regulation of Th1/Th2 responses. Semin Immunol (2001) 1.34
A defined donor activating natural killer cell receptor genotype protects against leukemic relapse after related HLA-identical hematopoietic stem cell transplantation. Leukemia (2005) 1.33
Signal recognition particle-dependent protein targeting, universal to all kingdoms of life. Rev Physiol Biochem Pharmacol (2002) 1.33
The injection of deaggregated gamma globulins in adult mice induces antigen-specific unresponsiveness of T helper type 1 but not type 2 lymphocytes. J Exp Med (1992) 1.32
Crystal structures of Escherichia coli aspartate aminotransferase in two conformations. Comparison of an unliganded open and two liganded closed forms. J Mol Biol (1994) 1.32
Organ involvement and phenotypic adhesion profile of 5T2 and 5T33 myeloma cells in the C57BL/KaLwRij mouse. Br J Cancer (1997) 1.30
Role of CD8alpha+ and CD8alpha- dendritic cells in the induction of primary immune responses in vivo. J Leukoc Biol (1999) 1.30
Induction of effective therapeutic antitumor immunity by direct in vivo administration of lentiviral vectors. Gene Ther (2006) 1.30
The adjuvant monophosphoryl lipid A increases the function of antigen-presenting cells. Int Immunol (2000) 1.28
Biclonal B-cell lymphoma. N Engl J Med (1984) 1.27
Human dendritic cell responses to lipopolysaccharide and CD40 ligation are differentially regulated by interleukin-10. Eur J Immunol (1997) 1.27
Lentiviral vectors for cancer immunotherapy: transforming infectious particles into therapeutics. Gene Ther (2007) 1.27
Incidence of dysplasia and carcinoma of the uterine cervix in an Appalachian population. J Natl Cancer Inst (1992) 1.26
Hypothermia and hypoglycemia induced by anti-CD3 monoclonal antibody in mice: role of tumor necrosis factor. Eur J Immunol (1990) 1.26
Image-based point spread function implementation in a fully 3D OSEM reconstruction algorithm for PET. Phys Med Biol (2010) 1.24
Interleukin-10 prevents the generation of dendritic cells from human peripheral blood mononuclear cells cultured with interleukin-4 and granulocyte/macrophage-colony-stimulating factor. Eur J Immunol (1997) 1.24
Cytokine release syndrome induced by the 145-2C11 anti-CD3 monoclonal antibody in mice: prevention by high doses of methylprednisolone. J Immunol (1991) 1.22
Mechanism and kinetics of factor VIII inactivation: study with an IgG4 monoclonal antibody derived from a hemophilia A patient with inhibitor. Blood (1998) 1.22
Antigen-specific T lymphocytes regulate lipopolysaccharide-induced apoptosis of dendritic cells in vivo. J Immunol (1998) 1.22
Transcriptional regulation of the AP-2alpha promoter by BTEB-1 and AP-2rep, a novel wt-1/egr-related zinc finger repressor. Mol Cell Biol (1999) 1.21
Developmental fate of ovoid oocytes. Hum Reprod (2007) 1.18
Endogenously produced substance P contributes to lymphocyte proliferation induced by dendritic cells and direct TCR ligation. Eur J Immunol (1999) 1.16
Comparison of hydrochlorothiazide and sustained-release diltiazem for mild-to-moderate systemic hypertension. Am J Cardiol (1987) 1.15
Evidence that the clonogenic cell in multiple myeloma originates from a pre-switched but somatically mutated B cell. Br J Haematol (1994) 1.14
Crystal structure of GABA-aminotransferase, a target for antiepileptic drug therapy. Biochemistry (1999) 1.14
The 15-Country Collaborative Study of Cancer Risk among Radiation Workers in the Nuclear Industry: study of errors in dosimetry. Radiat Res (2007) 1.13
Revisiting the Th1/Th2 paradigm. Scand J Immunol (1998) 1.13
Regulation of T helper cell differentiation in vivo by soluble and membrane proteins provided by antigen-presenting cells. Eur J Immunol (1998) 1.13
Interleukin-12-activated natural killer cells recognize B7 costimulatory molecules on tumor cells and autologous dendritic cells. Blood (1998) 1.12
Age-related decrease in the inducibility of heat-shock protein 70 in human peripheral blood mononuclear cells. J Clin Immunol (2002) 1.12
A MAGE-A3 peptide presented by HLA-DP4 is recognized on tumor cells by CD4+ cytolytic T lymphocytes. Cancer Res (2000) 1.12
Mouse CD-RAP/MIA gene: structure, chromosomal localization, and expression in cartilage and chondrosarcoma. Dev Dyn (1997) 1.11
Embryo fragmentation in vitro and its impact on treatment and pregnancy outcome. Fertil Steril (2001) 1.11
Peroxisome proliferator-activated receptor gamma activators inhibit interleukin-12 production in murine dendritic cells. FEBS Lett (2000) 1.10